Variant report

Variant	nsv1008984
Chromosome Location	chr3:68718875-68747401
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr3:68714555..68717541-chr3:68719964..68722635,2	K562	blood:
2	chr1:95699874..95700489-chr3:68738675..68739508,2	HCT-116	colon:

Extended variants
information (count: 142 )
Associated
traits (count: 85 )

Variant overlapped rSNPs/rCNVs (count:142 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs202182473	chr3:68718924-68718925	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs553508987	chr3:68718959-68718960	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs564051236	chr3:68718982-68718983	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs528803484	chr3:68718997-68718998	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs183521074	chr3:68718998-68718999	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs533013249	chr3:68719050-68719051	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs565169380	chr3:68719093-68719094	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs115680005	chr3:68719096-68719097	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs550305205	chr3:68719098-68719099	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs1875829	chr3:68719119-68719120	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs535828200	chr3:68719211-68719212	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs9813609	chr3:68719218-68719219	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
13	rs529072633	chr3:68719234-68719235	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs566623201	chr3:68719236-68719237	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs145584256	chr3:68719260-68719261	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs558763229	chr3:68719283-68719284	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs575557207	chr3:68719289-68719290	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs113060080	chr3:68719317-68719318	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs557136948	chr3:68719322-68719323	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs574080918	chr3:68719348-68719349	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs371530911	chr3:68719366-68719367	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs542626403	chr3:68719370-68719371	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs559712460	chr3:68719371-68719372	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs367826299	chr3:68719396-68719397	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs112871874	chr3:68719397-68719398	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs371852603	chr3:68719494-68719495	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs375293106	chr3:68719506-68719507	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs188115587	chr3:68719507-68719508	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs565132152	chr3:68719571-68719572	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs367575875	chr3:68719656-68719657	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs531047747	chr3:68719660-68719661	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs573871317	chr3:68719670-68719671	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs386662039	chr3:68719671-68719672	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs200592729	chr3:68719672-68719673	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs58476444	chr3:68719687-68719688	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs544662353	chr3:68719689-68719690	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs60398035	chr3:68719691-68719692	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs201048059	chr3:68719699-68719700	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs75633996	chr3:68719702-68719703	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs551162787	chr3:68719713-68719714	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs146959063	chr3:68719758-68719759	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs149943954	chr3:68735042-68735043	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs147613011	chr3:68735044-68735045	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs142130983	chr3:68735062-68735063	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs561013652	chr3:68735081-68735082	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs556911239	chr3:68735103-68735104	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs186317943	chr3:68735139-68735140	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs573812179	chr3:68735152-68735153	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs566800413	chr3:68735167-68735168	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs550685077	chr3:68735201-68735202	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:85)

Disease	PMID	Source
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
Acute myeloid leukemia	20729466	CNVD
Glioblastoma multiforme	21080181	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Breast cancer	17133270	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	21251322	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Squamous cell cancer	20885788	CNVD
Breast cancer	16608533	CNVD
Prostate cancer	21965145	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	19490591	CNVD
Autism	18414403	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Non-small cell lung cancer	20864512	CNVD
Metastatic melanoma	17975146	CNVD
Breast cancer	21509527	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Autism	22102821	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Prostate cancer	17217626	CNVD
Urothelial cell carcinoma	18451213	CNVD
Alzheimer''s disease	22166940	CNVD
Mental retardation	20848658	CNVD
Breast cancer	17142309	CNVD
Breast cancer	21364760	CNVD
lymphocytic leukemia	21291569	CNVD
Urothelial carcinoma	21177765	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Alcoholism	21790672	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:13 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:68716400-68719400	Weak transcription	Aorta	Aorta
2	chr3:68717400-68719000	Weak transcription	Fetal Brain Female	brain
3	chr3:68718800-68719800	Enhancers	Fetal Stomach	stomach
4	chr3:68719000-68719200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
5	chr3:68719000-68719200	Enhancers	Fetal Brain Female	brain
6	chr3:68719400-68719600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
7	chr3:68719400-68719600	Enhancers	Aorta	Aorta
8	chr3:68735000-68735600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr3:68741200-68741600	Enhancers	iPS-20b Cell Line	embryonic stem cell
10	chr3:68741600-68744000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
11	chr3:68743600-68744200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
12	chr3:68744000-68744800	Enhancers	ES-I3 Cell Line	embryonic stem cell
13	chr3:68744000-68744800	Enhancers	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links